The dimeric structure of factor XI and zymogen activation

Blood

Volumn 121, Issue 19, 2013, Pages 3962-3969

  Geng, Yipeng ^a   Verhamme, Ingrid M ^a   Smith, Stephen B ^a   Sun, Mao fu ^a   Matafonov, Anton ^a   Cheng, Qiufang ^a   Smith, Stephanie A ^b   Morrissey, James H ^b   Gailani, David ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12A; ENZYME PRECURSOR; BLOOD CLOTTING FACTOR 11A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; TRANSIENT EXPRESSION; ANIMAL; BIOLOGICAL MODEL; BLOOD CLOTTING FACTOR 11 DEFICIENCY; C57BL MOUSE; CELL STRAIN HEK293; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE;

ANIMALS; CAROTID ARTERY THROMBOSIS; FACTOR XI; FACTOR XI DEFICIENCY; FACTOR XIA; FACTOR XIIA; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY;

MLCS; MLOWN;

EID: 84880500380     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-473629     Document Type: Article

References (49)

1. Emsley J, McEwan PA, Gailani D. Structure and function of factor XI. Blood. 2010;115(13): 2569-2577.
2. Bouma BN, Griffin JH. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977;252(18): 6432-6437.
3. Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry. 1986;25(9): 2417-2424.
4. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry. 1991;30(8): 2056-2060.
5. Papagrigoriou E, McEwan PA, Walsh PN, Emsley J. Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nat Struct Mol Biol. 2006;13(6):557-558.
6. Ponczek MB, Gailani D, Doolittle RF. Evolution of the contact phase of vertebrate blood coagulation. J Thromb Haemost. 2008;6(11):1876-1883.
7. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry. 1991;30(8):2050-2056.
8. Hooley E, McEwan PA, Emsley J. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation. J Thromb Haemost. 2007;5(12):2461-2466.
9. Wu W, Sinha D, Shikov S, et al. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa. J Biol Chem. 2008;283(27): 18655-18664.
10. Zucker M, Zivelin A, Landau M, Rosenberg N, Seligsohn U. Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI. J Thromb Haemost. 2009; 7(6):970-975.
11. Cheng Q, Tucker EI, Pine MS, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood. 2010;116(19): 3981-3989.
12. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991;266(12):7353-7358.
13. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science. 1991;253(5022):909-912.
14. Matafonov A, Sarilla S, Sun M-F, Sheehan JP, Serebrov V, Verhamme IM, Gailani D. Activation of factor XI by products of prothrombin activation. Blood. 2011;118(2):437-445.
15. Smith SB, Verhamme IM, Sun M-F, Bock PE, Gailani D. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation. J Biol Chem. 2008;283(11):6696-6705.
16. Gailani D, Broze GJ Jr. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis. 1993;4(1): 15-20.
17. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011;118(26):6963-6970.
18. Cheng Q, Sun M-F, Kravtsov DV, Aktimur A, Gailani D. Factor XI apple domains and protein dimerization. J Thromb Haemost. 2003;1(11): 2340-2347.
19. Liu F, Song YK, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6(7): 1258-1266.
20. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 1999;10(10):1735-1737.
21. Sebestyén MG, Budker VG, Budker T, et al. Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med. 2006;8(7):852-873.
22. Gailani D, Lasky NM, Broze GJ Jr. A murine model of factor XI deficiency. Blood Coagul Fibrinolysis. 1997;8(2):134-144.
23. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010; 116(20):4353-4359.
24. Johnson KA, Simpson ZB, Blom T. Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data. Anal Biochem. 2009;387(1):20-29.
25. Meijers JC, Mulvihill ER, Davie EW, Chung DW. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry. 1992; 31(19):4680-4684.
26. Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost. 2002;87(4):774-776.
27. Wang X, Cheng Q, Xu L, et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost. 2005;3(4):695-702.
28. Renné T, Pozgajová M, Grüner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005;202(2):271-281.
29. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139(6): 1143-1156.
30. Samuel D, Cheng H, Riley PW, et al. Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation. Proc Natl Acad Sci USA. 2007;104(40):15693-15698.
31. Soslau G, Goldenberg SJ, Class R, Jameson B. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin. Platelets. 2004;15(3):155-166.
32. Sinha D, Marcinkiewicz M, Gailani D, Walsh PN. Molecular cloning and biochemical characterization of rabbit factor XI. Biochem J. 2002;367(Pt 1):49-56.
33. MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 1964;202:498-499.
34. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science. 1964;145(3638): 1310-1312.
35. Gailani D, Renné T, Emsley J. Factor XI and the contact system. In: Valle D, Beaudet AL, Vogelstein B, et al, eds. The Online Metabolic and Molecular Basis of Inherited Disease. Philadelphia: Lippincott, Williams, and Wilkins; 2010
36. Meijers JC, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood. 1992;79(6):1435-1440.
37. Kravtsov DV, Wu W, Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 2004;104(1): 128-134.
38. Saito H, Ratnoff OD, Bouma BN, Seligsohn U. Failure to detect variant (CRM1) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds. J Lab Clin Med. 1985;106(6): 718-722.
39. Furie B, Furie BC. Molecular basis of blood coagulation. In: Hematology: Basic Principles and Practice. 5th ed. Philadelphia: Churchill Livingstone-Elsevier; 2009: 1819-1836.
40. Spronk HMH, Wilhelm S, Heemskerk H, et al. Feedback activation of factor XI by thrombin is essential for haemostasis in vivo. J Thromb Haemost. 2009;7(Supl 2):PL-TU-003.
41. Baglia FA, Walsh PN. A binding site for thrombin in the apple 1 domain of factor XI. J Biol Chem. 1996;271(7):3652-3658.
42. Kornberg A, Rao NN, Ault-Riché D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem. 1999;68:89-125.
43. Yun TH, Morrissey JH. Polyphosphate and omptins: novel bacterial procoagulant agents. J Cell Mol Med. 2009;13(10):4146-4153.
44. Smith SA, Morrissey JH. Polyphosphate as a general procoagulant agent. J Thromb Haemost. 2008;6(10):1750-1756.
45. Wu W, Roder H, Walsh PN. Conformational changes facilitate FXI autoactivation to FXIa [abstract]. Blood. 2010;116:Abstract 19.
46. Revenko AS, Gao D, Crosby JR, et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood. 2011;118(19): 5302-5311.
47. Ho DH, Badellino K, Baglia FA, Sun MF, Zhao MM, Gailani D, Walsh PN. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface. J Biol Chem. 2000;275(33): 25139-25145.
48. White-Adams TC, Berny MA, Tucker EI, et al. Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol. 2009;29(10): 1602-1607.
49. Gailani D, Ho D, Sun M-F, Cheng Q, Walsh PN. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood. 2001;97(10): 3117-3122.